摘要
目的观察轻型急性胆源性胰腺炎(MABP)患者一期行腹腔镜胆囊切除术的可行性及安全性。方法将我院2015年1~12月一期行腹腔镜胆囊切除术的32例MABP患者设为观察组;同期有MABP病史,经对症治疗病情缓解出院,2~6周再次入院行腹腔镜胆囊切除术的29例患者设为对照组,比较两组患者的手术时间、住院总时间、术后肛门排气时间、治疗费用、术后并发症及复发情况。结果两组患者的平均手术时间、术后肛门排气时间比较差异均无统计学意义(P>0.05);观察患者人均总住院时间为(12.06±1.63)d,明显短于对照组的(31.62±5.14)d,人均治疗费用为(8 792.43±183.27)元,明显低于对照组的(19 037.66±208.54)元,差异均有统计学意义(P<0.05);观察组患者术后并发症发生率为3.13%;对照组为0;两组术后并发症发生率比较差异无统计学意义(P>0.05);两组患者术后均随访12个月,无一例复发。结论 MABP患者一期行腹腔镜胆囊切除术安全可行,且可缩短住院时间,节省医疗费用。
Objective To observe the feasibility and safety of laparoscopic cholecystectomy（LC） in patients with stage Ⅰ mild acute biliary pancreatitis（MABP）. Methods A total of 32 patients with stage Ⅰ MABP, who underwent laparoscopic cholecystectomy from January 2015 to December 2015, were selected as the observation group. At the same time, 29 patients who had a history of MABP, discharged after remission with the symptomatic treatment and again underwent LC for readmission after 2~6 weeks, were chosen as the control group. The operative time, hospitalization time, postoperative anal exhaust time, treatment cost, postoperative complications, and recurrence were compared between the two groups. Results There were no significant differences in the average operation time and postoperative anal exhaust time between the two groups（P〉0.05）. The total hospitalization time and treatment cost of the observation group were respectively（12.06±1.63） d and（8 792.43±183.27） yuan, which were significantly lower than（31.62±5.14）d and（19 037.66 ± 208.54） yuan of the control group（P〈0.05）. There was no significant difference in the incidence of postoperative complications between the observation group（3.13%） and the control group（0）（P〉0.05）. The two groups were followed up for 12 months, and no recurrence was observed. Conclusion LC is safe and feasible for the patients with stage I MABP, which can also shorten the hospitalization time and save medical costs.
出处
《海南医学》
CAS
2017年第7期1154-1156,共3页
Hainan Medical Journal
关键词
轻型急性胆源性胰腺炎
腹腔镜胆囊切除术
可行性
安全性
Mild acute biliary pancreatitis（MABP）
Laparoscopic cholecystectomy（LC）
Feasibility
Safety
